BiotechTube
Home/Adlai Nortye/Kefei Ren
KR

Kefei Ren

Chief Operating Officer

Adlai Nortye

Therapeutic Areas

Oncology

Adlai Nortye Pipeline

DrugIndicationPhase
AN2025 (Buparlisib)Recurrent or metastatic Head and Neck Squamous Cell CarcinomaPhase 3
AN0025 (Eganelisib)Locally Advanced Rectal CancerPhase 1b/2
AN4005Advanced or Metastatic Solid TumorsPhase 1
AN8025Advanced Solid TumorsPhase 1
AN1025Advanced Solid TumorsPhase 1
AN9025Not SpecifiedPreclinical
AN3025Not SpecifiedPreclinical
AN2025SNot SpecifiedPreclinical

Leadership Team at Adlai Nortye

LB
Lars Birgerson
President & Chief Executive Officer
PZ
Peter Zhang
Chief Scientific Officer
MM
Mao Mao
Chief Medical Officer
CG
Caroline Germa
Executive Vice President, Global Development
ML
Mingjun Liu
Chief Financial Officer
View full Adlai Nortye profile